Testing effectiveness (Phase 2)Study completedNCT00215644
What this trial is testing
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer
Who this might be right for
Esophageal CancerGastric Cancer
Merck KGaA, Darmstadt, Germany 72